Bacil Pharma Limited submitted a letter to the General Manager of the Listing Compliance Department at BSE Limited. The purpose of the communication was a regulatory compliance disclosure.
The company stated that it had not entered into any Related Party Transactions during the quarter or half year ended 31st March 2026. Consequently, the disclosure of Related Party Transactions, which must be submitted in the format prescribed under an applicable SEBI Circular, was reported as "Nil" for the specified period.
The company requested that the exchange take this information on record.
The letter was digitally signed by Ms. Chaitali Kalpataru Shah, who is identified as a Director & CFO of Bacil Pharma Limited. Her DIN is 11167778. The letter was dated 22nd May 2026 and issued from Mumbai.